261 related articles for article (PubMed ID: 31771252)
21. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Rumora L; Rajković MG; Kopčinović LM; Pancirov D; Čepelak I; Grubišić TŽ
COPD; 2014 Sep; 11(5):539-45. PubMed ID: 24831724
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.
Costa LG; Giordano G; Furlong CE
Biochem Pharmacol; 2011 Feb; 81(3):337-44. PubMed ID: 21093416
[TBL] [Abstract][Full Text] [Related]
23. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
24. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
[TBL] [Abstract][Full Text] [Related]
25. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
26. Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL.
Gugliucci A; Kinugasa E; Ogata H; Caccavello R; Kimura S
Clin Chim Acta; 2014 Mar; 430():9-14. PubMed ID: 24384301
[TBL] [Abstract][Full Text] [Related]
27. The paraoxonase 1, 2 and 3 in humans.
Rajkovic MG; Rumora L; Barisic K
Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
[TBL] [Abstract][Full Text] [Related]
28. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
29. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia.
van Himbergen TM; Roest M; de Graaf J; Jansen EH; Hattori H; Kastelein JJ; Voorbij HA; Stalenhoef AF; van Tits LJ
J Lipid Res; 2005 Mar; 46(3):445-51. PubMed ID: 15576850
[TBL] [Abstract][Full Text] [Related]
30. Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice.
Farrell N; Norris G; Lee SG; Chun OK; Blesso CN
Food Funct; 2015 Apr; 6(4):1278-87. PubMed ID: 25758596
[TBL] [Abstract][Full Text] [Related]
31. Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus.
Zhou M; Liu XH; Liu QQ; Chen M; Bai H; Jiang CY; Guan LB; Fan P
Pediatr Res; 2021 Apr; 89(5):1192-1199. PubMed ID: 32570269
[TBL] [Abstract][Full Text] [Related]
32. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
[TBL] [Abstract][Full Text] [Related]
33. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
34. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Liu ML; James RW; Ylitalo K; Taskinen MR
Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
36. Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis.
Castañé H; Jiménez-Franco A; Martínez-Navidad C; Placed-Gallego C; Cambra-Cortés V; Perta AM; París M; Castillo DD; Arenas M; Camps J; Joven J
Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136158
[TBL] [Abstract][Full Text] [Related]
37. Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: studies in cultured hepatocytes in vitro and in rat liver in vivo.
Schrader C; Ernst IM; Sinnecker H; Soukup ST; Kulling SE; Rimbach G
J Cell Mol Med; 2012 Oct; 16(10):2331-41. PubMed ID: 22304296
[TBL] [Abstract][Full Text] [Related]
38. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
39. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
Bae SS; Shahbazian A; Wang J; Golub I; Oganesian B; Dowd T; Vayngortin B; Wang R; Elashoff D; Reddy ST; Charles-Schoeman C
Rheumatology (Oxford); 2022 May; 61(6):2512-2523. PubMed ID: 34698804
[TBL] [Abstract][Full Text] [Related]
40. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes.
Mahrooz A; Alizadeh A; Gohari G
J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
